Mark Kessel

Mark Kessel is the founder of Symphony Capital LLC, which was founded in 2002.
He held the title of Partner from 2011 to 2012.
Mr. Kessel was also the founder of Symphony Icon, Inc. Mr. Kessel's current job(s) included being the Chairman of Foundation for Innovative New Diagnostics, Chairman of Symphony ViDA, Inc., Director of Biotechnology Innovation Organization, Director of Symphony Dynamo, Inc., Director of Fondation Santé, and Member-Development Committee of Symphony Evolution, Inc.Mr. Kessel's former job(s) included being the Chairman of Symphony Neuro Development Co., Director of Oncotelic Therapeutics, Inc. from 2008 to 2011, Director of Agenus, Inc. from 2003 to 2006, Director of Dynavax Technologies Corp., and Director of Global Alliance for TB Drug Development.
He also served as an Independent Director of Organovo Holdings, Inc. from 2016 to 2020 and as a Director of Symphony Genisis, Inc. Mr. Kessel was also Of Counsel at Shearman & Sterling LLP from 1971 to 2019.
Mr. Kessel's education includes an undergraduate degree from The City College of New York and a graduate degree from Syracuse University College of Law.